InMed Pharmaceuticals Inc. - Common Shares, no par value (INM)
CUSIP: 457637601
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Common Shares, no par value
- Shares outstanding
- 804,525
- Total 13F shares
- 685,852
- Share change
- -118,299
- Total reported value
- $249,191
- Price per share
- $0.36
- Number of holders
- 14
- Value change
- -$42,696
- Number of buys
- 5
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 457637601?
CUSIP 457637601 identifies INM - InMed Pharmaceuticals Inc. - Common Shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 457637601:
Top shareholders of INM - InMed Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC |
13F
|
Company |
64%
|
511,934
|
$212,965 | — | 31 Dec 2023 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
26%
|
205,968
|
$85,683 | — | 31 Dec 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
4.8%
|
38,900
|
$16,000 | — | 31 Dec 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
4.2%
|
34,009
|
$14,148 | — | 31 Dec 2023 | |
| Bruce Colwill |
3/4/5
|
CFO |
—
class O/S missing
|
11,515
|
$10,294 | — | 24 Jan 2022 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
1.6%
|
12,894
|
$5,364 | — | 31 Dec 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.02%
|
200
|
$83 | — | 31 Dec 2023 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0.01%
|
85
|
$43 | — | 31 Dec 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
100
|
$42 | — | 31 Dec 2023 | |
| Advisory Services Network, LLC |
13F
|
Company |
0.01%
|
59
|
$25 | — | 31 Dec 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
41
|
$15 | — | 31 Dec 2023 | |
| AllSquare Wealth Management LLC |
13F
|
Company |
0%
|
21
|
$9 | — | 31 Dec 2023 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
19
|
$8 | — | 31 Dec 2023 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0%
|
12
|
$5 | — | 31 Dec 2023 | |
| Global Retirement Partners, LLC |
13F
|
Company |
0%
|
6
|
$2 | — | 31 Dec 2023 | |
| TORONTO DOMINION BANK |
13F
|
Company |
0%
|
2
|
$1 | — | 31 Dec 2023 | |
| Mr. Jonathan Tegge |
3/4/5
|
Interim CFO |
—
class O/S missing
|
31,400
|
— | — | 23 Dec 2023 | |
| Catherine Sazdanoff |
3/4/5
|
Director |
—
class O/S missing
|
29,091
|
— | — | 29 Dec 2021 | |
| Adam D. Cutler |
3/4/5
|
Director |
—
class O/S missing
|
16,122
|
— | — | 24 Jan 2022 | |
| Mr. William J. Garner |
3/4/5
|
Director |
—
class O/S missing
|
16,122
|
— | — | 24 Jan 2022 | |
| Ms. Sarah Li |
3/4/5
|
VP Accounting & Controller |
—
class O/S missing
|
4,002
|
— | — | 16 Dec 2022 |
Institutional Holders of InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) as of Q1 2024
As of 31 Mar 2024,
InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
685,852 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, ARMISTICE CAPITAL, LLC, RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA SECURITIES, LLC, CITADEL ADVISORS LLC, BFSG, LLC, Qube Research & Technologies Ltd, BANK OF AMERICA CORP /DE/, AdvisorNet Financial, Inc, and UBS Group AG.
This page lists
14
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
13
Q1 2024 holders
14
Holder diff
1
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.